ACORDA THERAPEUTICS INC's ticker is and the CUSIP is 00484MAA4. A total of 35 filers reported holding ACORDA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $4,368,000 | -32.3% | 5,500,000 | -26.7% | 0.27% | -17.8% |
| Q2 2019 | $6,453,000 | -53.0% | 7,500,000 | -51.2% | 0.32% | -60.0% |
| Q1 2019 | $13,716,000 | +350.4% | 15,372,000 | +284.3% | 0.81% | +181.0% |
| Q4 2016 | $3,045,000 | +23.2% | 4,000,000 | +33.3% | 0.29% | -17.0% |
| Q3 2016 | $2,472,000 | – | 3,000,000 | – | 0.35% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opti Capital Management, LP | 7,500 | $6,276,000 | 2.99% |
| PFM Health Sciences, LP | 90,886,000 | $75,652,000 | 2.01% |
| Jabre Capital Partners S.A. | 1,750,000 | $1,474,000 | 1.68% |
| Partner Investment Management, L.P. | 1,108,000 | $922,000 | 1.15% |
| Telemetry Investments, L.L.C. | 2,000,000 | $1,655,000 | 1.06% |
| Worth Venture Partners, LLC | 1,562,000 | $1,312,000 | 0.99% |
| DLD Asset Management, LP | 12,000,000 | $10,028,000 | 0.69% |
| Castle Creek Arbitrage, LLC | 2,310,000 | $1,937,000 | 0.67% |
| CANYON CAPITAL ADVISORS LLC | 28,775,000 | $23,830,000 | 0.56% |
| SYMPHONY ASSET MANAGEMENT LLC | 2,000,000 | $1,665,000 | 0.49% |